Vladimir T Valuev-Elliston

23PUBLICATIONS
57CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesCardiology (incl. cardiovascular diseases)Injury prevention
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 22, 2026
CRISPR-Cas genome editing system in the diagnosis and therapy of infection caused by herpes simplex virus type 1 (<i>Orthoherpesviridae: Alphaherpesviridae: Simplexvirus: Simplexvirus humanalpha1</i>).

N A Demidova, R R Klimova, A A Kushch

|Nov 25, 2025
[Resistance and chemosensitivity restoration in human cytomegalovirus-infected tumor cells to doxorubicin through combined treatment with aqueous fullerene dC<sub>60</sub>].

Y Y Chernoryzh, K I Yurlov, T V Grebennikova

|Nov 13, 2025
Sumac Polyphenols as Pan-Herpesvirus Inhibitors.

Shavkat I Salikhov, Yuliya I Oshchepkova, Jamolitdin F Ziyavitdinov

|Oct 28, 2025
Occult hepatitis B: prevalence and clinical significance. Role in liver pathology and in viral coinfections.

A A Kushch

|Nov 27, 2024
Control of HSV-1 Infection: Directions for the Development of CRISPR/Cas-Based Therapeutics and Diagnostics.

Anastasiia O Sosnovtseva, Natalia A Demidova, Regina R Klimova

|Jun 06, 2024
[Detection rates and high concentration of herpesvirus (Orthoherpesviridae) DNA in autopsy materials from patients with COVID-19 fatal outcome].

K I Yurlov, S A Yakushina, N E Fedorova

Pageof 4

Frequent Collaborators

13 joint publications

Regina R Klimova

11 joint publications

Olga V Masalova

10 joint publications

Natalya A Demidova

9 joint publications

Ekaterina I Lesnova